Trial Profile

A Cross-Sectional Study of Patients with Chronic Immune Thrombocytopenic Purpura and Caregivers to Estimate the Proportion who Administer Romiplostim Correctly After Receipt of Home Administration Training Materials

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 27 Sep 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

19 Sep 2018 Primary endpoint (Correct administration of romiplostim) has been met, as per the results published in the Drug Safety
19 Sep 2018 Results published in the Drug Safety
30 Aug 2017 Results presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com